EVO logo

Evotec SE (EVO)

Profile

Full Name

Evotec SE

Ticker Symbol

EVO

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Germany

IPO

February 5, 2004

Indexes

Not included

Website

http://www.evotec.com

Employees

5007

Key Details

Price

$3.27(-2.97%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$845.98M(+6.75% YoY)

Annual EPS

-$0.25(+51.26% YoY)

PE ratio

-

Next earnings date

Apr 17, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$3.27
EVO price is $3.27

30-Day Relative Volume

0.49
EVO 30-day relative volume is 0.49

Price Performance

Price Most recent change

-2.97%
EVO price was down -2.97% on Apr 16, 2025

Price YTD change

-21.39%
EVO price is down -21.39% since January 1st

Price 1-year change

-53.35%
EVO price is down -53.35% year-on-year

Price 3-year change

-75.92%
EVO price is down -75.92% over the past 3 years

Price Range

Price All-time high

$26.57
EVO price is currently -87.69% below its historical high of $26.57

Price 3-year low

$2.84
EVO price is currently +15.14% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.16B
EVO market capitalization is $1.16 billion

Market cap 3-year change

-75.84%
EVO market capitalization is down -75.84% over the past 3 years

Market cap All-time high

$8.73B
EVO market capitalization is currently -86.70% below its historical high of $8.73 billion

Market cap sector rank

78.37%
EVO market capitalization is higher than 78.37% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.21%
EVO shares outstanding is up +0.21% year-on-year

Shares Outstanding 3-Year Change

+0.34%
EVO shares outstanding is up +0.34% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.79
EVO beta is 0.79

200-day SMA

$4.03
EVO price is currently -18.86% below its 200-day simple moving average

50-day SMA

$3.79
EVO price is currently -13.70% below its 50-day simple moving average

RSI

44.46
EVO 14-day relative strength index is 44.46

Volume

0.49
EVO 30-day relative volume is 0.49

ATR

$0.16
EVO average true range is $0.16

10-day Historical Volatility

67.65%
EVO 10-day historical volatility is 67.65%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$845.98M
EVO annual revenue is $845.98 million

Revenue Analysts estimate

$797.01M
EVO annual revenue is currently +6.14% higher than the consensus analysts' forecast

Revenue 1-year change

+6.75%
EVO annual revenue is up +6.75% year-on-year

Revenue Sector rank

79.55%
EVO annual revenue is higher than 79.55% of companies in Healthcare sector

EPS

EPS

-$0.25
EVO annual earnings per share is -$0.25

EPS Analysts estimate

-$0.90
EVO annual earnings per share is currently -71.73% lower than the consensus analysts' forecast

EPS 1-year change

+51.26%
EVO annual earnings per share is up +51.26% year-on-year

EPS Sector rank

76.14%
EVO annual earnings per share is higher than 76.14% of companies in Healthcare sector

Profit

Gross profit

$189.51M
EVO annual gross profit is $189.51 million

Gross margin

22.40%
EVO annual gross profit margin is 22.40%

Operating profit

-$46.01M
EVO annual operating income is -$46.01 million

Operating margin

-5.44%
EVO annual operating profit margin is -5.44%

Net income

-$90.84M
EVO annual net profit is -$90.84 million

Net margin

-10.74%
EVO annual net profit margin is -10.74%

Expenses

Total expenses

$891.99M
EVO annual total expenses is $891.99 million

Operating expenses

$235.52M
EVO annual total operating expenses is $235.52 million

Cost of goods sold

$656.47M
EVO annual cost of goods sold is $656.47 million

Selling, general & administrative expenses

$183.62M
EVO annual SGA is $183.62 million

Depreciation and amortization

$100.66M
EVO annual depreciation & amortization is $100.66 million

Interest expense

$12.71M
EVO annual interest expense is $12.71 million

Income tax

$3.59M
EVO annual income tax is $3.59 million

EBIT & EBITDA

EBIT

-$74.54M
EVO annual earnings before interest & taxes is -$74.54 million

EBITDA

$26.12M
EVO annual EBITDA is $26.12 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$2.49B
EVO annual total assets is $2.49 billion

Non current assets

$1.49B
EVO annual long term assets is $1.49 billion

Current assets

$998.36M
EVO annual total current assets is $998.36 million

Cash and cash equivalents

$564.76M
EVO annual cash & cash equivalents is $564.76 million

Accounts receivable

$108.77M
EVO annual accounts receivable is $108.77 million

Inventory

$34.15M
EVO annual inventory is $34.15 million

Liabilities

Total liabilities

$1.25B
EVO annual total liabilities is $1.25 billion

Long term liabilities

$738.39M
EVO annual total long term liabilities is $738.39 million

Current liabilities

$513.54M
EVO annual total current liabilities is $513.54 million

Accounts payable

$148.48M
EVO annual accounts payable is $148.48 million

Debt

Total debt

$692.21M
EVO annual total debt is $692.21 million

Total debt 1-year change

+27.4%
EVO annual total debt is up +27.4% year-on-year

Long term debt

$527.40M
EVO annual long term debt is $527.40 million

Short term debt

$164.81M
EVO annual short term debt is $164.81 million

Equity & Capital

Shareholders equity

$1.24B
EVO annual stockholders equity is $1.24 billion

Book value

$1.24B
EVO annual book value is $1.24 billion

Retained earnings

-$526.49M
EVO annual retained earnings is -$526.49 million

Working capital

$484.82M
EVO annual working capital is $484.82 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$39.45M
EVO annual cash flow from operations is $39.45 million

Cash from operations 1-year change

-81.58%
EVO annual cash flow from operations is down -81.58% year-on-year

Cash from investing

-$14.39M
EVO annual cash flow from investing activities is -$14.39 million

Cash from investing 1-year change

+96.72%
EVO annual cash flow from investing activities is up +96.72% year-on-year

Cash from financing

$77.91M
EVO annual cash flow from financing activities is $77.91 million

Cash from financing 1-year change

+240.94%
EVO annual cash flow from financing activities is up +240.94% year-on-year

CAPEX

CAPEX

$233.84M
EVO annual capital expenditures is $233.84 million

CAPEX 1-year change

+22.27%
EVO annual capital expenditures is up +22.27% year-on-year

Free Cash Flow

Free cash flow

-$194.39M
EVO annual free cash flow is -$194.39 million

Free cash flow 1-year change

-947.41%
EVO annual free cash flow is down -947.41% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

22.40%
EVO annual gross profit margin is 22.40%

Operating margin

-5.44%
EVO annual operating profit margin is -5.44%

Net margin

-10.74%
EVO annual net profit margin is -10.74%

ROA & ROE

ROA

-3.70%
EVO annual return on assets is -3.70%

ROE

-7.24%
EVO annual return on equity is -7.24%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
EVO price to earnings ratio value is unknown

PE ratio Sector rank

-
EVO price to earnings ratio is unknown

PB Ratio

PB ratio

1.07
EVO price to book ratio is 1.07

PB ratio Sector rank

46.17%
EVO price to book ratio is higher than 46.17% of companies in Healthcare sector

PS Ratio

PS ratio

1.38
EVO price to sales ratio is 1.38

PS ratio Sector rank

34.23%
EVO price to sales ratio is higher than 34.23% of companies in Healthcare sector

Enterprise value

Enterprise value

$1.43B
EVO enterprise value is $1.43 billion

Enterprise value Sector rank

78.58%
EVO enterprise value is higher than 78.58% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-6.88
EVO EV/EBITDA is -6.88

EV/EBITDA Sector rank

15.06%
EVO EV/EBITDA is higher than 15.06% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.94
EVO annual current ratio is 1.94

Quick ratio

1.88
EVO annual quick ratio is 1.88

Leverage

Debt to equity

0.56
EVO annual debt to equity ratio is 0.56

Interest coverage ratio

-5.87
EVO annual interest coverage ratio is -5.87

Risk & Stability

Piotroski F-Score

2
EVO piotroski f-score is 2

Altman Z-Score

0.74
EVO altman z-score is 0.74

Analyst ratings

Recent major analysts updates

Nov 7, 24 HC Wainwright & Co.
Buy
Aug 15, 24 HC Wainwright & Co.
Buy
May 23, 24 HC Wainwright & Co.
Buy
Apr 25, 24 HC Wainwright & Co.
Buy
Aug 31, 23 HC Wainwright & Co.
Buy
Jul 12, 23 HC Wainwright & Co.
Buy
Jun 23, 23 Morgan Stanley
Overweight
Jun 16, 23 B of A Securities
Neutral
Jun 8, 23 Citigroup
Buy
Apr 4, 23 Morgan Stanley
Equal-Weight

Institutional Ownership

Similar stocks

AZTA logo
Azenta (AZTA)
LQDA logo
Liquidia (LQDA)
Kestra Medical Technologies (KMTS)
TNDM logo
Tandem Diabetes Care (TNDM)
CLDX logo
Celldex Therapeutics (CLDX)
OCUL logo
Ocular Therapeutix (OCUL)
PLSE logo
Pulse Biosciences (PLSE)
INVA logo
Innoviva (INVA)
PCRX logo
Pacira BioSciences (PCRX)
  • What is the ticker symbol for Evotec SE?
  • Does Evotec SE pay dividends?
  • What sector is Evotec SE in?
  • What industry is Evotec SE in?
  • What country is Evotec SE based in?
  • When did Evotec SE go public?
  • Is Evotec SE in the S&P 500?
  • Is Evotec SE in the NASDAQ 100?
  • Is Evotec SE in the Dow Jones?
  • When was Evotec SE's last earnings report?
  • When does Evotec SE report earnings?

What is the ticker symbol for Evotec SE?

The ticker symbol for Evotec SE is NASDAQ:EVO

Does Evotec SE pay dividends?

No, Evotec SE does not pay dividends

What sector is Evotec SE in?

Evotec SE is in the Healthcare sector

What industry is Evotec SE in?

Evotec SE is in the Drug Manufacturers - Specialty & Generic industry

What country is Evotec SE based in?

Evotec SE is headquartered in Germany

When did Evotec SE go public?

Evotec SE's initial public offering (IPO) was on February 5, 2004

Is Evotec SE in the S&P 500?

No, Evotec SE is not included in the S&P 500 index

Is Evotec SE in the NASDAQ 100?

No, Evotec SE is not included in the NASDAQ 100 index

Is Evotec SE in the Dow Jones?

No, Evotec SE is not included in the Dow Jones index

When was Evotec SE's last earnings report?

Evotec SE's most recent earnings report was on Nov 6, 2024

When does Evotec SE report earnings?

The next expected earnings date for Evotec SE is Apr 17, 2025
On this page